Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enanta
Biotech
Enanta RSV antiviral reduces viral load in ph. 2 pediatric trial
Enanta’s zelicapavir reduced viral load in children, maintaining hopes the biotech can find a niche in a market dominated by Big Pharma vaccines.
James Waldron
Dec 9, 2024 9:35am
Enanta's RSV antiviral crushes viral load in challenge study
Sep 26, 2024 7:43am
Enanta halts work on joint hMPV-RSV drug to extend cash to 2027
Nov 21, 2023 8:30am
Enanta makes the case for COVID-19 antiviral's mixed data
May 9, 2023 9:47am
Where are they now? Tracking down 2012's Fierce 15
Aug 29, 2022 3:00am
Enanta sinks to multiyear low as phase 2b RSV trial flames out
May 19, 2022 8:47am
